|

PainCeptor Pharma Corporation, a new leading-edge biopharmaceutical company focused on novel and effective therapeutic drugs for the treatment of acute and chronic pain, successfully completed a Cdn$23 million initial private placement. PainCeptor Pharma Corporation was created as a result of the merger of Antalium Inc. and Neuroceptor Inc., two spin-off companies of McGill and Queen's Universities respectively.

|

2004